SELECT FROM MENU

Therapy Areas
Drug Classes

       Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Advanced NSCLC

Advanced NSCLC

SCLC

SCLC

Biomarkers

Biomarkers

       Drug Classes

Targeted Therapies

Targeted Therapies

Immunotherapies

Immunotherapies

ADCs

ADCs

Rolf A. Stahel

Rolf A. Stahel

ETOP-IBCSG Partners Foundation, Bern

Prof. Rolf A. Stahel is President of the ETOP-IBCSG Partners Foundation in Bern, Switzerland, and remains affiliated with University Hospital Zurich and the University of Zurich. His thoracic oncology research spans EGFR-, ALK- and KRAS-mutated non-small cell lung cancer, malignant pleural mesothelioma, and translational biomarker work. He co-founded the European Thoracic Oncology Platform and its Lungscape registry, led trials including the ETOP BOOSTER study, served as ESMO President, and received the 2025 ESMO Lifetime Achievement Award. He is also Vice-President of the International Cancer Foundation. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Rolf A. Stahel

Featured in